Vaccine

04/05/2019

Korean vaccines expanding global territory

The Seoul Economic Daily published an article in Korean about the Korean vaccine industry. The article describes the growth of the Korean vaccine industry and has two favorable mentions of IVI’s role. Shown below is a translation of the article. –Ed.   Korean vaccines expanding global territory […]
04/08/2019

Student engagement program cited by foreign school

  IVI has been featured in Seoul Foreign School’s Work Experience Program brochure. In May of 2018, eleven SFS students participated in the program with support from volunteer Dr. Silvia Kim. They learned basic techniques in cellular immunology in the IVI labs and had the […]
04/09/2019

IVI DG gives keynote at ‘International Symposium on Epidemics Preparedness Using ICT’

Key attendees pose for a commemorative photo   Dr. Jerome Kim delivers his keynote address   IVI Director General Dr. Jerome Kim was invited as a keynote speaker at the ‘International Symposium on Epidemics Preparedness Using ICT’ at the Korean National Assembly on April 3, […]
04/09/2019

EuBiologics inaugurates 2nd manufacturing plant in Chuncheon, Korea

Dr. Baik Yeong-Ok, CEO of EuBiologics, and Dr. Jerome Kim, Director General of IVI pose together at the inauguration of EuBiologics’ Second Plant in Chuncheon, Korea on April 9, 2019.   EuBiologics, the manufacturer of Euvichol® and Euvichol-Plus® oral cholera vaccine, and an important partner […]
DONATE